Mer regulates microglial/macrophage M1/M2 polarization and alleviates neuroinflammation following traumatic brain

Haijian Wu1,2,3, Jingwei Zheng1, Shenbin Xu1

  • 1Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.

Abstract

Insights

Myeloid-epithelial-reproductive tyrosine kinase (Mer) regulates brain inflammation after traumatic brain injury (TBI). Inhibiting Mer worsens TBI outcomes, suggesting Mer is a potential therapeutic target for TBI.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Traumatic brain injury (TBI) is a major global health issue, characterized by microglial/macrophage activation and neuroinflammation.
  • The precise regulatory mechanisms of these innate immune responses in TBI remain incompletely understood.
  • Myeloid-epithelial-reproductive tyrosine kinase (Mer), a receptor tyrosine kinase, influences microglial/macrophage functions, but its role in TBI-induced neuroinflammation and polarization is unexplored.

Purpose of the Study:

  • To investigate the role of Mer in regulating microglial/macrophage M1/M2 polarization and neuroinflammation following TBI.
  • To elucidate the downstream signaling pathways modulated by Mer in the context of TBI.

Main Methods:

  • Utilized the controlled cortical impact (CCI) mouse model for TBI induction.
  • Administered Mer siRNA and recombinant protein S (PS) for targeted intervention.
  • Performed comprehensive assessments including neurobehavioral tests, molecular analyses (RT-PCR, Western blot), cell sorting, immunohistochemistry, and histological staining.

Main Results:

  • Mer expression is upregulated in the acute phase of TBI, correlating with microglial/macrophage M1/M2 polarization and neuroinflammation.
  • Mer activation of the STAT1/SOCS1/3 pathway was identified as a key mechanism.
  • Mer inhibition shifted polarization towards M1-like phenotypes, exacerbating brain damage and sensorimotor deficits; conversely, recombinant PS demonstrated protective effects.

Conclusions:

  • Mer plays a critical role in modulating microglial/macrophage polarization and neuroinflammation post-TBI.
  • Mer represents a promising therapeutic target for mitigating secondary brain injury and improving outcomes in TBI patients.